CytoMed Therapeutics (GDTC) Change in Acquisitions & Divestments (2023 - 2025)
CytoMed Therapeutics (GDTC) posted Change in Acquisitions & Divestments of $273320.0 for Q2 2025, up 157.22% sequentially from -$477677.0 in Q2 2024, and up 157.22% YoY from $106259.8 in Q2 2024.
CytoMed Therapeutics (GDTC) Change in Acquisitions & Divestments (2023 - 2025) Analysis & Trends
CytoMed Therapeutics has reported Change in Acquisitions & Divestments for 3 years, with the latest figure at $273320.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CytoMed Therapeutics | 10.72 Mn | 9.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 273,320.00 |
| Jun 30, 2025 | 273,320.00 |
| Jun 30, 2024 | -477,677.00 |
| Jun 30, 2024 | -477,677.00 |
| Jun 30, 2023 | -5.44 Mn |
| Jun 30, 2023 | -5.44 Mn |